Joseph S. Konowiecki, Executive Vice President of Corporate Affairs and Director at Alignment Healthcare, Inc. (NASDAQ:ALHC), filed a Form 4 on September 18, 2026, reporting the sale of common stock on September 17, 2026, to cover tax withholding obligations tied to vesting restricted stock units.
Key Highlights
- Shares sold: 23,511 shares of Alignment Healthcare common stock were disposed of on September 17, 2026.
- Weighted-average price: The reported sale price was $8.61 per share, reflecting transactions ranging from $8.285 to $8.915 per share.
- Purpose of sale: According to the filing, the shares were sold solely to cover tax withholding obligations connected to the vesting of restricted stock units, and "this transaction does not represent a discretionary trade by the reporting person."
- Remaining ownership: Following the transaction, Konowiecki directly beneficially owned 1,080,305 shares of common stock.
- Reporting person roles: Konowiecki is identified in the filing as both a Director and an Officer with the title EVP, Corporate Affairs.
Konowiecki RSU Vesting Triggers Mandatory Tax-Related Share Sale
According to the Form 4 filed with the Securities and Exchange Commission, Joseph S. Konowiecki disposed of 23,511 shares of Alignment Healthcare, Inc. common stock on September 17, 2026. The filing uses transaction code "S," indicating a sale. The filing states that the shares sold represent "the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units," and explicitly notes the transaction was not a discretionary trade.
The sale was executed at a weighted-average price of $8.61 per share. The filing discloses that individual transactions occurred at prices ranging from $8.285 to $8.915 per share across multiple executions. The filing further states that Konowiecki, through his attorney-in-fact Christopher J. Joyce, undertakes to provide full information on the number of shares sold at each price within that range upon request by Alignment Healthcare, any security holder, or SEC staff.
After the reported transaction, Konowiecki's direct beneficial ownership in Alignment Healthcare common stock stood at 1,080,305 shares, according to the filing. No derivative securities transactions were reported in Table II of the form. The filing was signed by Christopher J. Joyce as attorney-in-fact for Konowiecki and dated September 18, 2026.
What Was Disclosed
The filing reports a mandatory sale of 23,511 Alignment Healthcare common shares by EVP Joseph S. Konowiecki on September 17, 2026, at a weighted-average price of $8.61 per share, solely to satisfy tax withholding on vested restricted stock units, leaving him with 1,080,305 shares directly owned.




Please wait processing your request...